IP Library Patent Application 12183412
Patent Application
App. No. 12/183,412

Method and system for biopsy and analysis of a body tissue

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/183,412
Abstract

Methods and systems for performing biopsies and diagnosing tumors and suspect masses within the body. A biopsy sample is frozen while still in the body of a patient, then removed from the patient, stored frozen, and subject to IHC, microarray or other analysis to determine the amount, type or presence of signaling substances within the tumor or suspect mass.

Claims (19)

1 . A method for diagnosing and treating breast tumors comprising:

freezing a biopsy sample within a breast tumor;

excising the frozen biopsy sample from the breast tumor after freezing;

testing the biopsy sample for the presence of a signaling substance which indicates the susceptibility of the breast tumor to a course of treatment;

diagnosing the tumor based on the presence of the signaling substance within the biopsy sample.

2 . The method of claim 1 , wherein the testing comprises:

testing the biopsy sample with a microarray to determine the amount of mRNA in the biopsy sample.

3 . The method of claim 1 , wherein the testing comprises:

testing the biopsy sample with a microarray to determine the type of mRNA in the biopsy sample.

4 . The method of claim 1 , wherein the testing comprises:

testing the biopsy sample with a microarray to determine the presence or amount of mutant mRNA in the biopsy sample.

5 . The method of claim 1 , wherein the testing comprises:

testing the biopsy sample with a microarray to determine the amount of HER-2/Neu in the biopsy sample.

6 . The method of claim 1 , wherein the testing comprises:

testing the biopsy sample with a microarray to determine the amount of HER-1 in the biopsy sample.

7 . The method of claim 1 , wherein the testing comprises:

testing the biopsy sample with a microarray to determine the amount of ERBB2 in the biopsy sample.

8 . The method of claim 1 , wherein the testing comprises:

testing the biopsy sample with a microarray to determine the amount of vascular endothelial growth factor receptor (VEGFR) in the biopsy sample.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 3, 2013
From: HORIZON TECHNOLOGY FUNDING COMPANY LLC
To: SANARUS TECHNOLOGIES, LLC
Reel/Frame 030144/0939 →
RELEASE OF SECURITY INTEREST Recorded Oct 15, 2009
From: HORIZON TECHNOLOGY FUNDING COMPANY LLC
To: SANARUS MEDICAL INCORPORATED
Reel/Frame 023373/0658 →
SECURITY AGREEMENT Recorded Oct 15, 2009
From: SANARUS TECHNOLOGIES, LLC
To: HORIZON TECHNOLOGY FUNDING COMPANY LLC
Reel/Frame 023373/0908 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2009
From: SANARUS MEDICAL, INC.
To: SANARUS TECHNOLOGIES, LLC
Reel/Frame 023220/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2008
From: BLOOM, KENNETH; STABINSKY, SETH A.
To: SANARUS MEDICAL, INC.
Reel/Frame 021323/0313 →